EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women

Yasir S Elhassan iD, James M Hawley, Leanne Cussen, Ali Abbara iD, Sophie A Clarke, Punith Kempegowda, Rima K Dhillon-Smith, Puja Thadani, Maureen Busby, Lucy Owusu-Darkwah, Rachel Marrington, W Colin Duncan und 3 weitere

Clinical Endocrinology · 2025-10 · 103 (4) · 540-566

DOI: 10.1111/cen.15265 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Endocrinology, online erschienen am 13.05.2025. Verfasst von Yasir S Elhassan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Androgens, Endocrinology, Hyperandrogenism. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, Contributors in this work receive research funding from the following: MWOR: Health Research Board Emerging Clinician Scientist Award (ECSA-2020-001); A.A.: NI….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Androgen excess is common in women and refers to clinical or biochemical evidence of elevated androgenic steroids such as testosterone. It is associated with underlying polycystic ovary syndrome in the majority of cases. However severe androgen excess is less common and may indicate the presence of underlying adrenal or ovarian neoplasms, genetic disorders or severe insulin resistance syndromes. Currently there are few consensus guidelines to assist clinicians with a standardised management approach to the patient with severe androgen excess.

Design

Clinical practice guideline.

Methods

This guideline has been developed with expertise from colleagues in endocrinology, gynaecology, clinical biochemistry and nursing, and furthermore provides a unique patient perspective to guide clinicians.

Results

The Society for Endocrinology commissioned this new guideline to collate multi‐disciplinary guidance for clinical practitioners in the investigation of severe androgen excess. Recommendations have been made in the areas of clinical assessment, biochemical work up, dynamic testing and imaging, informed where possible by the best available evidence.

Conclusion

This guideline will provide guidance for clinicians in their approach to patients with severe androgen excess.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrogensEndocrinologyHyperandrogenismHumansFemalePolycystic Ovary SyndromeTestosterone

Stichwörter der Autor:innen

adrenalandrogen excessovariansevere insulin resistancetestosteronevirilisation

Substanzen

AndrogensTestosterone

Autor:innen und Institutionen

  • Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Department of Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Department of Clinical Biochemistry, Manchester University NHS Foundation Trust, Manchester, UK.
  • Medical Research Council Laboratory of Medical Sciences, London, UK.
  • Department of Medicine, Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland.
  • Section of Investigative Medicine, Imperial College London, London, UK.

ORCID-Profile: Yasir S Elhassan, Ali Abbara, Richard Quinton, Michael W O'Reilly

Förderung

  • Wellcome Trust
  • Contributors in this work receive research funding from the following: MWOR: Health Research Board Emerging Clinician Scientist Award (ECSA-2020-001); A.A.: NI…

Zitieren

APA

Elhassan, Y. S., Hawley, J. M., Cussen, L., Abbara, A., Clarke, S. A., Kempegowda, P., Dhillon-Smith, R. K., Thadani, P., Busby, M., Owusu-Darkwah, L., Marrington, R., Duncan, W. C., Semple, R. K., Quinton, R., & O'Reilly, M. W. (2025). Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women. Clinical Endocrinology, 103(4), 540-566. https://doi.org/10.1111/cen.15265

Vancouver

Elhassan YS, Hawley JM, Cussen L, Abbara A, Clarke SA, Kempegowda P, et al. Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women. Clinical Endocrinology. 2025;103(4):540-566. doi:10.1111/cen.15265

BibTeX
@article{Elhassan2025,
  author = {Elhassan, Yasir S and Hawley, James M and Cussen, Leanne and Abbara, Ali and Clarke, Sophie A and Kempegowda, Punith and Dhillon-Smith, Rima K and Thadani, Puja and Busby, Maureen and Owusu-Darkwah, Lucy and Marrington, Rachel and Duncan, W Colin and Semple, Robert K and Quinton, Richard and O'Reilly, Michael W},
  title = {Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women},
  journal = {Clinical Endocrinology},
  year = {2025},
  volume = {103},
  number = {4},
  pages = {540--566},
  doi = {10.1111/cen.15265}
}
Kostenlos starten →